Biomanufacturing Increases Available Supply of Anti-cancer Drug
![](https://biosciences.lbl.gov/wp-content/uploads/2022/09/saccharomyces-cerevisiae-yeast-budding-cell-under-the-microscope-picture-id1201053290.png)
The supply of a plant-derived anti-cancer drug can finally meet global demand after a team of scientists from Denmark and the U.S. engineered yeast to produce the precursor molecules, which could previously only be obtained in trace concentrations in the native plant. A study describing the breakthrough was recently published in Nature. The international team included four researchers from the Biological Systems and Engineering Division: Leanne Jade G. Chan, Edward Baidoo, Christopher J. Petzold, and Jay D. Keasling.
More »